These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12915448)

  • 1. The Lafora disease gene product laforin interacts with HIRIP5, a phylogenetically conserved protein containing a NifU-like domain.
    Ganesh S; Tsurutani N; Suzuki T; Ueda K; Agarwala KL; Osada H; Delgado-Escueta AV; Yamakawa K
    Hum Mol Genet; 2003 Sep; 12(18):2359-68. PubMed ID: 12915448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization of laforin, a dual-specificity protein phosphatase implicated in Lafora disease.
    Girard JM; Lê KH; Lederer F
    Biochimie; 2006 Dec; 88(12):1961-71. PubMed ID: 17010495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laforin, defective in the progressive myoclonus epilepsy of Lafora type, is a dual-specificity phosphatase associated with polyribosomes.
    Ganesh S; Agarwala KL; Ueda K; Akagi T; Shoda K; Usui T; Hashikawa T; Osada H; Delgado-Escueta AV; Yamakawa K
    Hum Mol Genet; 2000 Sep; 9(15):2251-61. PubMed ID: 11001928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional and developmental expression of Epm2a gene and its evolutionary conservation.
    Ganesh S; Agarwala KL; Amano K; Suzuki T; Delgado-Escueta AV; Yamakawa K
    Biochem Biophys Res Commun; 2001 May; 283(5):1046-53. PubMed ID: 11355878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
    Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
    Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen and related polysaccharides inhibit the laforin dual-specificity protein phosphatase.
    Wang W; Roach PJ
    Biochem Biophys Res Commun; 2004 Dec; 325(3):726-30. PubMed ID: 15541350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutational spectrum of the EPM2A gene in progressive myoclonus epilepsy of Lafora: high degree of allelic heterogeneity and prevalence of deletions.
    Gómez-Garre P; Sanz Y; Rodríguez De Córdoba SR; Serratosa JM
    Eur J Hum Genet; 2000 Dec; 8(12):946-54. PubMed ID: 11175283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carbohydrate-binding domain of Lafora disease protein targets Lafora polyglucosan bodies.
    Ganesh S; Tsurutani N; Suzuki T; Hoshii Y; Ishihara T; Delgado-Escueta AV; Yamakawa K
    Biochem Biophys Res Commun; 2004 Jan; 313(4):1101-9. PubMed ID: 14706656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laforin preferentially binds the neurotoxic starch-like polyglucosans, which form in its absence in progressive myoclonus epilepsy.
    Chan EM; Ackerley CA; Lohi H; Ianzano L; Cortez MA; Shannon P; Scherer SW; Minassian BA
    Hum Mol Genet; 2004 Jun; 13(11):1117-29. PubMed ID: 15102711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular genetics of epilepsy].
    Yamakawa K
    Rinsho Shinkeigaku; 2004 Nov; 44(11):858-60. PubMed ID: 15651314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel protein interacting with laforin, the EPM2a progressive myoclonus epilepsy gene product.
    Ianzano L; Zhao XC; Minassian BA; Scherer SW
    Genomics; 2003 Jun; 81(6):579-87. PubMed ID: 12782127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene.
    Ganesh S; Shoda K; Amano K; Uchiyama A; Kumada S; Moriyama N; Hirose S; Yamakawa K
    Mol Cell Probes; 2001 Oct; 15(5):281-9. PubMed ID: 11735300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Escherichia coli expression, refolding and characterization of human laforin.
    Castanheira P; Moreira S; Gama M; Faro C
    Protein Expr Purif; 2010 Jun; 71(2):195-9. PubMed ID: 20152902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chloroplast-localized dual-specificity protein phosphatase in Arabidopsis contains a phylogenetically dispersed and ancient carbohydrate-binding domain, which binds the polysaccharide starch.
    Kerk D; Conley TR; Rodriguez FA; Tran HT; Nimick M; Muench DG; Moorhead GB
    Plant J; 2006 May; 46(3):400-13. PubMed ID: 16623901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the structural insights on human laforin mutation K87A in Lafora disease--a molecular dynamics study.
    Srikumar PS; Rohini K
    Appl Biochem Biotechnol; 2013 Oct; 171(4):874-82. PubMed ID: 23904258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A unique carbohydrate binding domain targets the lafora disease phosphatase to glycogen.
    Wang J; Stuckey JA; Wishart MJ; Dixon JE
    J Biol Chem; 2002 Jan; 277(4):2377-80. PubMed ID: 11739371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy.
    Minassian BA; Ianzano L; Meloche M; Andermann E; Rouleau GA; Delgado-Escueta AV; Scherer SW
    Neurology; 2000 Aug; 55(3):341-6. PubMed ID: 10932264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of mouse homologue for the human epilepsy gene, EPM2A.
    Ganesh S; Amano K; Delgado-Escueta AV; Yamakawa K
    Biochem Biophys Res Commun; 1999 Apr; 257(1):24-8. PubMed ID: 10092504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between glycogen accumulation and the laforin dual specificity phosphatase.
    Wang W; Parker GE; Skurat AV; Raben N; DePaoli-Roach AA; Roach PJ
    Biochem Biophys Res Commun; 2006 Nov; 350(3):588-92. PubMed ID: 17022935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
    Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
    Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.